799
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Pulmonary artery coil embolisation prevented tumour progression in a patient with advanced squamous cell lung carcinoma

, , , &
Pages 257-261 | Received 13 Mar 2020, Accepted 03 Apr 2020, Published online: 30 Apr 2020

References

  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature 2018;553:446–54. doi:10.1038/nature25183
  • Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. CMAR. 2019;11:943–53. doi:10.2147/CMAR.S187317
  • Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5:288–300. doi:10.21037/tlcr.2016.06.07
  • Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA. Comparison of aspects of smoking among four histologic types of lung cancer. Tob Control. 2008;17:198–204. doi:10.1136/tc.2007.022582
  • Roth JA, Goulart BHL, Ravelo A, Kolkey H, Ramsey SD. Survival gains from first‐line systemic therapy in metastatic non‐small cell lung cancer in the U.S., 1990–2015: progress and opportunities. The Oncol. 2017;22:304–10. doi:10.1634/theoncologist.2016-0253
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.21442
  • Suh Y-G, Cho J. Local ablative radiotherapy for oligometastatic non-small cell lung cancer. Radiat Oncol J. 2019;37:149–55. doi:10.3857/roj.2019.00514
  • Ariza ‐Prota M, Martínez C, Casan P. Spontaneous regression of metastatic squamous cell lung cancer. Clin Case Rep. 2018;6:995–8. doi:10.1002/ccr3.1502
  • Chung C, Park DI, Kim SY, Kim JO, Jung SS, Park HS, et al. Spontaneous regression of non-small cell lung cancer that progressed after multiple chemotherapies: a case report. Thorac Cancer. 2015;6:805–7. doi:10.1111/1759-7714.12221
  • Everson TC. Spontaneous regression of cancer. Prog Clin Cancer 1967;3:79–95.
  • Jessy T. Immunity over inability: the spontaneous regression of cancer. J Nat Sci Biol Med. 2011;2:43–9. doi:10.4103/0976-9668.82318
  • Deng J, Tang J, Shen N. Meta-analysis of diagnosis of liver metastatic cancers: comparison of 18FDG PET-CT and gadolinium-enhanced MRI. J Med Imaging Radiat Oncol. 2014;58:532–7. doi:10.1111/1754-9485.12231
  • Gladwish A, Clarke K, Bezjak A. Spontaneous regression in advanced non-small cell lung cancer. BMJ Case Rep. 2010;2010:bcr0720103147. doi:10.1136/bcr.07.2010.3147
  • Tadmor T. Time to understand more about spontaneous regression of cancer. Acta Haematol. 2019;141:156–7. doi:10.1159/000496680
  • Ogawa R, Watanabe H, Yazaki K, Fujita K, Tsunoda Y, Nakazawa K, et al. Lung cancer with spontaneous regression of primary and metastatic sites: a case report. Oncol Lett. 2015;10:550–2. doi:10.3892/ol.2015.3243
  • Lopez-Pastorini A, Plönes T, Brockmann M, Ludwig C, Beckers F, Stoelben E. Spontaneous regression of non-small cell lung cancer after biopsy of a mediastinal lymph node metastasis: a case report. J Med Case Reports. 2015;9:217. doi:10.1186/s13256-015-0702-9
  • Ooi KH, Cheo T, Soon GST, Leong CN. Spontaneous regression of locally advanced nonsmall cell lung cancer. Medicine (Baltimore). 2018;97:e11291. doi:10.1097/MD.0000000000011291
  • Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann Oncol. 2002;13:165–9. doi:10.1093/annonc/mdf655
  • Jászai J, Schmidt M. Trends and challenges in tumor anti-angiogenic therapies. Cells 2019;8:pii:1102. doi:10.3390/cells8091102
  • Niu G, Chen X. PET imaging of angiogenesis. PET Clin. 2009;4:17–38. doi:10.1016/j.cpet.2009.04.011
  • Lorenz JM, Navuluri R. Embolization of chest neoplasms: the next frontier in interventional oncology? Semin Intervent Radiol. 2019;36:176–82. doi:10.1055/s-0039-1692658
  • Kumar T, Patel N, Talwar A. Spontaneous regression of thoracic malignancies. Respir Med. 2010;104:1543–50. doi:10.1016/j.rmed.2010.04.026
  • Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non–small-cell lung cancer. JCO. 2008;26:3543–51. doi:10.1200/JCO.2007.15.0375
  • Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WEE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer. N Engl J Med. 2015;373:123–35. doi:10.1056/NEJMoa1504627